Corient Registered Alternatives Fund
Consolidated Schedule of Investments
June 30, 2026 (Unaudited)
| Investments - 102.9% | Investment Type | Acquisition Date | Shares | Cost | Fair Value | |||||||||
| Direct Investments - 3.8% | ||||||||||||||
| Direct Equity - 3.8% | ||||||||||||||
| North America - 3.8% | ||||||||||||||
| AUA Famiglia Co-Investors Feeder, LLC*1,4 | Units | 5/1/2026 | 2,574 | $ | 2,712,257 | $ | 2,574,000 | |||||||
| Crimson FLS Topco, LP*1,4 | Class A Common Units | 2/18/2026 | 40,000 | 4,000,000 | 3,974,640 | |||||||||
| Harvest Group Topco Holdings, LP (Class A Common Units)*1,4 | Class A Common Units | 2/27/2026 | 4,293 | - | - | |||||||||
| Harvest Group Topco Holdings, LP (Preferred Units)*1,4 | Preferred Units | 2/27/2026 | 4,293 | 4,293,000 | 4,440,294 | |||||||||
| KKEMP Blocked Co-Invest, LP*1,4 | Class A Interest | 7/15/2025 | 3,000 | 3,088,008 | 3,479,523 | |||||||||
| Lettermen's Parent Holding, LLC (Class A)*1,4 | Class A Units | 11/20/2025 | 27,000 | 2,700,000 | 2,837,367 | |||||||||
| Lettermen's Parent Holding, LLC (Common)*1,4 | Common Units | 12/5/2025 | 3,281 | 328,053 | 344,743 | |||||||||
| NP/BF Holdings, LP*1,4 | Partnership Interest | 4/30/2025 | 5,000 | 5,000,000 | 3,774,101 | |||||||||
| Rocket Ultimate, LP*1,4 | Class A Common Units | 2/19/2026 | 3,393,000 | 3,393,000 | 3,393,000 | |||||||||
| TBG Acquisitions, Inc.*1,4 | Preferred Equity | 6/12/2026 | 5,000 | 5,000,000 | 5,000,000 | |||||||||
| Total Direct Equity | 30,514,318 | 29,817,668 | ||||||||||||
| Total Direct Investments - 3.8% | 30,514,318 | 29,817,668 | ||||||||||||
| Investment Funds - 83.7% | ||||||||||||||
| Direct Equity - 20.1% | ||||||||||||||
| North America - 20.1% | ||||||||||||||
| 8VC CHSD, LLC*1 | Non-Managing Member | 12/8/2025 | N/A | $ | 2,000,000 | $ | 1,999,342 | |||||||
| 8VC STSD, LLC*1 | Non-Managing Member | 3/20/2026 | N/A | 5,000,000 | 5,000,000 | |||||||||
| 26N Ignite Co-Investment Partners, LP*1 | Limited Partnership | 6/11/2026 | N/A | 4,560,894 | 4,550,000 | |||||||||
| 26N Nova Co-investment Partners, LP1 | Limited Partnership | 11/30/2025 | N/A | 10,000,000 | 11,332,171 | |||||||||
| BayPine Monarch Co-Invest, LP*1 | Limited Partnership | 6/24/2025 | N/A | 5,089,613 | 5,598,305 | |||||||||
| BayPine Regal Co-Invest, LP*1 | Limited Partnership | 5/28/2026 | N/A | 5,000,000 | 5,000,000 | |||||||||
| Coalesce Diamond Coinvest, LP *1,2,3 | Limited Partnership | 5/21/2025 | N/A | 4,026,667 | 5,297,367 | |||||||||
| CPF Midway Fund-A, LP1,2 | Limited Partnership | 3/18/2025 | N/A | 3,901,367 | 5,144,791 | |||||||||
| EVE Bison Co-Invest A, LP*1 | Limited Partnership | 6/10/2026 | N/A | 4,113,000 | 4,113,000 | |||||||||
| GreyLion TGNL Holdings, LP*1,2,3 | Limited Partnership | 6/20/2025 | N/A | 3,963,864 | 7,870,741 | |||||||||
| HighBrook US DCF, LP*1,2 | Limited Partnership | 8/25/2025 | N/A | 4,433,861 | 5,735,623 | |||||||||
| LC10 Flash Non-U.S. Aggregator, LP1 | Limited Partnership | 12/22/2025 | N/A | 9,126,136 | 15,056,264 | |||||||||
| LH Equity Investors, LP*1 | Limited Partnership | 9/3/2025 | N/A | 4,812,500 | 6,795,896 | |||||||||
| NMSEF II Aggregator, LP*1 | Limited Partnership | 9/29/2025 | N/A | 3,315,208 | 3,546,561 | |||||||||
| Run Ventures II CIV-C, LP*1 | Limited Partnership | 2/6/2026 | N/A | 1,512,488 | 1,901,764 | |||||||||
| Schill Blocker Aggregator, LLC *1 | Limited Partnership | 12/12/2025 | N/A | 5,000,000 | 4,965,273 | |||||||||
| Three Rivers Co-Investment, LP*1 | Limited Partnership | 11/7/2025 | N/A | 3,605,175 | 3,600,000 | |||||||||
| Uplift Investors Finch Co-invest Fund, LP*1 | Limited Partnership | 3/31/2026 | N/A | 4,500,000 | 4,500,000 | |||||||||
| Variant Income Opportunities Fund, LP1,2 | Limited Partnership | 1/22/2026 | N/A | 14,200,000 | 14,517,046 | |||||||||
| VEPF VIII Co-Invest 7-A, LP*1 | Limited Partnership | 12/29/2025 | N/A | 2,114,583 | 2,008,612 | |||||||||
| Vested 2022 03 61287, a Series of Vested Master, LLC*1 | Non-Managing Member | 3/13/2026 | N/A | 2,716,857 | 5,470,406 | |||||||||
| Vested Fund IV, LP*1 | Limited Partnership | 12/16/2025 | N/A | 18,000,000 | 24,240,479 | |||||||||
| WE Select Fund III, LP*1 | Limited Partnership | 9/10/2025 | N/A | 3,386,727 | 4,630,949 | |||||||||
| WP Silver Co-Invest, LP*1 | Limited Partnership | 6/24/2026 | N/A | 3,000,000 | 3,000,000 | |||||||||
| Total Direct Equity | 127,378,940 | 155,874,590 | ||||||||||||
| Liquid Income- 0.6% | ||||||||||||||
| North America - 0.6% | ||||||||||||||
| Vanguard Total Bond Market Index Fund | Institutional Shares | 3/4/2025 | 488,759 | 5,000,000 | 4,980,450 | |||||||||
| Total Liquid Income | 5,000,000 | 4,980,450 | ||||||||||||
| Other Income - 21.1% | ||||||||||||||
| North America - 21.1% | ||||||||||||||
| Artisan Global Unconstrained Fund | Institutional Shares | 6/8/2026 | 901,713 | 10,000,000 | 9,918,846 | |||||||||
| Axonic Strategic Income Fund I | Class I Shares | 2/3/2025 | 3,807,043 | 34,000,000 | 33,844,611 | |||||||||
| Cliffwater Enhanced Lending Fund CL | Ordinary Shares | 6/2/2025 | 2,533,657 | 28,000,000 | 27,718,212 | |||||||||
| Dawson Portfolio Finance Evergreen, LP | Limited Partnership, Class I-1 | 2/3/2025 | 45,722 | 46,000,000 | 45,979,519 | |||||||||
| Maxim Income Opportunity Fund I, LP2 | Limited Partnership | 2/3/2025 | N/A | 15,000,000 | 15,000,396 | |||||||||
| PIMCO Asset-Based Lending Company LLC - Series II | Series II - Anchor II | 8/1/2025 | 1,979,172 | 25,000,000 | 25,371,697 | |||||||||
| Revere Specialty Finance Fund, LP | Limited Partnership, Founders Class | 2/3/2025 | N/A | 5,000,000 | 5,117,278 | |||||||||
| Total Other Income | 163,000,000 | 162,950,559 | ||||||||||||
Corient Registered Alternatives Fund
Consolidated Schedule of Investments
June 30, 2026 (Unaudited) (Continued)
| Secondary Funds - 18.9% | ||||||||||||||
| Europe - 2.2% | ||||||||||||||
| CF24XB SCSp*1 | Limited Partnership | 6/12/2025 | N/A | 9,197,280 | 9,969,973 | |||||||||
| Hoxton Ventures III, LP*1,2,3 | Limited Partnership | 9/30/2025 | N/A | 1,733,426 | 2,826,339 | |||||||||
| KKR Next Generation Technology Growth Fund III, SCSp*1,2,3 | Limited Partnership | 9/30/2025 | N/A | 3,235,152 | 3,607,020 | |||||||||
| Total Europe | 14,165,858 | 16,403,332 | ||||||||||||
| North America - 16.7% | ||||||||||||||
| Cedar Holdings (Offshore), LP*1 | Limited Partnership | 9/30/2025 | N/A | 12,230,474 | 16,676,760 | |||||||||
| Corner Ventures DAG Fund I-A, LP*1 | Limited Partnership | 9/30/2025 | N/A | 2,293,538 | 3,099,947 | |||||||||
| CP EV Fund I, LP*1,2 | Limited Partnership | 3/30/2026 | N/A | 4,713,865 | 4,713,865 | |||||||||
| Falfurrias Capital Partners Crossover, LP*1,2 | Limited Partnership | 3/19/2026 | N/A | 5,118,768 | 5,055,097 | |||||||||
| Graham Partners GKP Continuation Fund, LP*1,2 | Class I Shares | 3/28/2025 | N/A | 4,270,424 | 3,723,640 | |||||||||
| Green Equity Investors CF IV-C, LP*1,2 | Limited Partnership | 4/15/2025 | N/A | 5,352,165 | 5,618,616 | |||||||||
| Green Equity Investors CF IV-J, LP1,2 | Limited Partnership | 4/30/2025 | N/A | 6,778,098 | 7,207,357 | |||||||||
| Hamilton Lane Impact Feeder Fund II, LP*1,2 | Limited Partnership | 9/30/2025 | N/A | 2,487,691 | 3,084,370 | |||||||||
| Iaso Fund, LP*1,2 | Limited Partnership | 12/12/2025 | N/A | 4,605,188 | 4,963,860 | |||||||||
| JLL Partners Fund VII Secondary (A), LP*1,2 | Limited Partnership | 4/28/2025 | N/A | 11,009,976 | 12,075,959 | |||||||||
| Littlejohn Altitude Fund, LP*1,2 | Limited Partnership | 5/19/2026 | N/A | 3,413,151 | 3,413,151 | |||||||||
| Lovell Minnick Equity Advisors VI, LP1,2 | Limited Partnership | 9/30/2025 | N/A | 4,802,876 | 5,698,385 | |||||||||
| LSCP BTX CV-B, LP*1,2 | Limited Partnership | 3/27/2026 | N/A | 3,656,224 | 3,804,720 | |||||||||
| Meranti ASEAN Growth Fund II, LP*1,2,3 | Limited Partnership | 9/30/2025 | N/A | 530,773 | 495,028 | |||||||||
| Miller Holdings (Offshore), LP - Common*1 | Limited Partnership, Class I-1 | 3/19/2025 | N/A | 7,690,244 | 9,239,424 | |||||||||
| Miller Holdings (Offshore), LP - Preferred1,2 | Class I Shares | 3/12/2025 | N/A | 5,552,018 | 5,113,851 | |||||||||
| Parthenon Kairos, LP8*1,2 | Limited Partnership | 3/2/2026 | N/A | 4,852,421 | 4,825,287 | |||||||||
| RCP Nats Co-Investment Fund, LP*1 | Limited Partnership | 3/12/2025 | N/A | 2,738,303 | 4,768,019 | |||||||||
| Sterling Investment Partners XK Opportunity Fund, LP and Fund-A, LP*1,2 | Limited Partnership | 10/23/2025 | N/A | 5,649,881 | 6,076,946 | |||||||||
| True Wind Capital II-A, LP*1,2 | Limited Partnership | 3/31/2025 | N/A | 2,554,597 | 2,712,105 | |||||||||
| Waud Capital Partners QP IV, LP*1,2,3 | Limited Partnership | 6/30/2025 | N/A | 2,987,188 | 2,675,277 | |||||||||
| Waud Capital Partners QP V, LP*1,2,3 | Limited Partnership | 6/30/2025 | N/A | 5,344,939 | 5,491,898 | |||||||||
| Waud Capital Partners QP VI, LP1,2,3 | Limited Partnership | 6/30/2025 | N/A | 1,280,134 | 1,353,777 | |||||||||
| WCAS XIV, LP*1,2,3 | Limited Partnership | 9/30/2025 | N/A | 6,254,583 | 8,163,872 | |||||||||
| Total North America | 116,167,519 | 130,051,211 | ||||||||||||
| Total Secondary Funds | 130,333,377 | 146,454,543 | ||||||||||||
Corient Registered Alternatives Fund
Consolidated Schedule of Investments
June 30, 2026 (Unaudited) (Continued)
| BDC - 8.7% | ||||||||||||||
| North America - 8.7% | ||||||||||||||
| Apollo Credit Strategies Absolute Return Fund, LP | Series B Interests | 6/1/2026 | N/A | 10,000,000 | 10,000,000 | |||||||||
| Blue Owl Credit Income Corp. | Class I Shares | 2/3/2025 | 1,307,260 | 12,421,261 | 11,869,920 | |||||||||
| Cliffwater Corp. Lending Fund I | Ordinary Shares | 2/3/2025 | 1,309,175 | 13,873,907 | 13,707,065 | |||||||||
| Fortress Private Lending Fund | Class I Shares | 8/1/2025 | 1,010,652 | 24,000,000 | 24,440,392 | |||||||||
| iDirect Private Credit Fund, LP | Class I Shares | 2/3/2025 | 714,556 | 7,100,000 | 6,995,499 | |||||||||
| Total BDC | 67,395,168 | 67,012,876 | ||||||||||||
| Unlisted REIT- 14.3% | ||||||||||||||
| North America - 14.3% | ||||||||||||||
| Fortress Net Lease REIT | Class F-I Shares | 2/3/2025 | 2,253,000 | 23,000,000 | 24,123,547 | |||||||||
| Invesco Commercial Real Estate Finance Trust, Inc. | Class I Shares | 3/3/2025 | 1,836,864 | 46,000,000 | 45,948,061 | |||||||||
| J.P. Morgan Real Estate Income Trust, Inc. | Class E Shares | 2/3/2025 | 3,548,356 | 40,000,000 | 40,917,508 | |||||||||
| Total Unlisted REIT | 109,000,000 | 110,989,116 | ||||||||||||
| Total Investment Funds - 83.7% | 602,107,485 | 648,262,134 | ||||||||||||
| Short-Term Investments - 15.4% | ||||||||||||||
| North America - 15.4% | ||||||||||||||
| Fidelity Institutional Government Portfolio - Class I, 3.53%5 | 119,211,722 | 119,211,722 | 119,211,722 | |||||||||||
| Total Short-Term Investments - 15.4% | 119,211,722 | 119,211,722 | ||||||||||||
| Total Investments - 102.9% | 751,833,525 | 797,291,524 | ||||||||||||
| Net Other Assets (Liabilites) - (2.9%) | (22,732,896 | ) | ||||||||||||
| Total Net Assets - 100.0% | $ | 774,558,629 | ||||||||||||
BDC - Business Development Company
REIT - Real Estate Investment Trust
| * | Investment is non-income producing. |
| 1 | Investment restricted for resale. Each investment may have been purchased on various dates and for different amounts. The date of the first purchase is reflected under Acquisition Date. Total fair value of restricted investments as of March 31, 2026, was $332,146,801, or 42.9% of net assets. Total cost of restricted investments as of March 31, 2026, was $288,226,635. |
| 2 | Investment has been committed to but has not been fully funded by the Fund. |
| 3 | All or a portion of this security is held through CoRA Blocker (US) LLC. |
| 4 | The fair value of the investment was determined using significant unobservable inputs. |
| 5 | The rate is the annualized seven-day yield as of March 31, 2026. |
See accompanying notes to the Schedule of Investments
Corient Registered Alternatives Fund
Notes to Consolidated Schedule of Investments (Unaudited)
June 30, 2026
Note 1 - Fair Value of Financial Instruments
The Fund values its investments at fair value in accordance with FASB ASC 820, Fair Value Measurement (“ASC 820”). The fair value of the Fund’s assets which qualify as financial instruments approximates the carrying amounts presented in the Consolidated Statement of Assets and Liabilities.
Investments for which market quotations are not readily available are valued at fair value as determined in good faith pursuant to Rule 2a-5 under the 1940 Act. As a general principle, the fair value of a security or other asset is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Pursuant to Rule 2a-5, the Board has designated the Adviser as the valuation designee (“Valuation Designee”) for the Fund to perform in good faith the fair value determination relating to all Fund investments, under the Board’s oversight. The Valuation Designee is responsible for developing the Fund’s written valuation processes and procedures, conducting periodic reviews of the valuation policies, and evaluating the overall fairness and consistent application of the valuation policies. The fair values of one or more assets may not be the prices at which those assets are ultimately sold, and the differences may be significant.
The Fund's portfolio investments are generally not in publicly traded securities (unless a portfolio company goes public and then only to the extent the Fund has not yet liquidated its securities holdings therein). Under the 1940 Act, for investments for which there are no readily available market quotations, including securities available on alternative trading systems and other private secondary markets, such securities are valued at fair value monthly as determined in good faith by the Adviser under consistently applied policies and procedures approved by the Board in accordance with GAAP. The Adviser may consult with the Subadviser in carrying out its responsibilities as valuation designee. In connection with the determination of fair value, the Adviser prepares portfolio company valuations using the most recent portfolio company financial statements and forecasts, if available. The Adviser may utilize the services of an independent valuation firm, which, if engaged, may prepare or review valuations for all or some of the Fund's portfolio investments that are not publicly traded or for which there are not readily available market quotations. The types of factors that the Adviser will take into account in providing a fair value determination with respect to such portfolio company valuation will include, as relevant and, to the extent available, the portfolio company's earnings, the markets in which the portfolio company does business, comparison to valuations of publicly traded companies in the portfolio company's industry, comparisons to recent sales of comparable companies, the discounted value of the cash flows of the portfolio company and other relevant factors. It is difficult to obtain financial and other information with respect to private companies, and even where the Fund is able to obtain such information, there can be no assurance that it is complete or accurate. Because such valuations are inherently uncertain and may be based on estimates, determinations of fair market value may differ materially from the values that would be assessed if a readily available market for these securities existed. Due to this uncertainty, fair market value determinations with respect to any non-publicly traded portfolio company investment may cause the Fund's NAV on a given date to materially understate or overstate the value that may ultimately be realized on one or more of the Fund's investments. As a result, investors purchasing Shares based on an overstated NAV would pay a higher price than the value of the Fund's investments might warrant. Conversely, investors redeeming Shares during a period in which the NAV understates the value of the Fund's investments will receive a lower price for their Shares than the value of the Fund's investments might warrant.
Certain investment funds that the Fund invests in (each, an “Investment Fund”) and certain direct investments in private credit and equity-related investments that are generally not publicly traded (“Direct Investments”) are valued based on the latest NAV reported by the third-party fund manager or general partner, as applicable. This includes adjusting the previous NAV provided by an investment manager with other relevant information available at the time the Fund values its portfolio, including capital activity and events occurring between the reference dates of the investment manager’s valuation and the relevant valuation date, to the extent that the Adviser is aware of such information. This is commonly referred to as using NAV as a practical expedient which allows for estimation of the fair value of a private investment based on NAV or its equivalent if the NAV of the private fund is calculated in a manner consistent with ASC 946.
Securities for which the primary market is a national securities exchange are valued at the last reported sales price on the day of valuation. Listed securities for which no sale was reported on that date are valued at the mean between the most recent bid and asked prices. Securities traded on the over-the-counter market are valued at their closing bid prices.
Corient Registered Alternatives Fund
Notes to Consolidated Schedule of Investments (Unaudited)
June 30, 2026 (Continued)
Note 2 – Fair Value Measurements
ASC 820 defines fair value as the value that the Fund would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent buyer in the principal market, or in the absence of a principal market, the most advantageous market to which the fund has access for the asset or liability. ASC 820 establishes a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in valuing the asset or liability developed based on the best information available in the circumstances. Each investment is assigned a level based upon the observation of the inputs which are significant to the overall valuation. The three-tier hierarchy of inputs is summarized below:
Level I: Quoted prices are available in active markets for identical investments as of the reporting date. The types of investments which would generally be included in Level I include listed equities.
Level II: Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies. The types of investments which would generally be included in Level II include corporate bonds and loans, and less liquid and restricted equity securities.
Level III: Pricing inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation. Those unobservable inputs, that are not corroborated by market data, generally reflect the reporting entity’s own assumptions about the assumptions market participants would use in determining the fair value of the investment. The types of investments which would generally be included in Level III include equity and/or debt securities issued by private entities and investments in private equity partnerships.
The Fund has established valuation processes and procedures to ensure that the valuation techniques are fair and consistent, and valuation inputs are supportable. The Fund’s investments in Investment Funds are carried at fair value which generally represents the Fund’s pro-rata interest in the net assets of each Investment Fund as reported by the administrators and/or investment managers of the underlying Investment Funds. All valuations utilize financial information supplied by each Investment Fund and are net of management and incentive fees or allocations payable to the Investment Funds’ managers or pursuant to the Investment Funds’ agreements. The Fund’s valuation procedures require the Valuation Designee to consider all relevant information available at the time the Fund values its portfolio. The Valuation Designee has assessed factors including, but not limited to, the individual Investment Funds’ compliance with fair value measurements, price transparency and valuation procedures in place. The Valuation Designee will consider such information and consider whether it is appropriate, in light of all relevant circumstances, to value such a position at its NAV as reported or whether to adjust such value. The fair value of an Investment Fund ordinarily will be the NAV of that Investment Fund determined and reported by the Investment Fund in accordance with the valuation policies established by the Investment Fund and/or its investment manager, absent information indicating that such NAV does not represent the fair value of the Investment Fund.
The fair value relating to certain underlying investments of these Investment Funds, for which there is no readily available market, has been estimated by the respective Investment Fund’s management and is based upon available information in the absence of readily ascertainable fair values and does not necessarily represent amounts that might ultimately be realized. Due to the inherent uncertainty of valuation, those estimated fair values may differ significantly from the values that would have been used had a ready market for the investments existed. These differences could be material.
The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities. The following is a summary of the inputs used, as of June 30, 2026, in valuing the Fund’s assets and liabilities carried at fair value:
| Level 1 | Level 2* | Level 3 | NAV as a Practical Expedient** | Total | ||||||||||||||||
| Investments | ||||||||||||||||||||
| Direct Investments | $ | — | $ | — | $ | 29,817,668 | $ | — | $ | 29,817,668 | ||||||||||
| Investment Funds1 | 97,164,683 | — | — | 551,097,451 | 648,262,134 | |||||||||||||||
| Short-Term Investments | 119,211,722 | — | — | — | 119,211,722 | |||||||||||||||
| Total Investments | $ | 216,376,405 | $ | — | $ | 29,817,668 | $ | 551,097,451 | $ | 797,291,524 | ||||||||||
| 1 | For a detailed break-out of Investment Funds by category, please refer to the Consolidated Schedule of Investments. |
| * | The Fund did not hold any Level 2 securities at period end. |
| ** | Direct Investments and Investment Funds that are measured at fair value using NAV (or its equivalent) as a practical expedient are not required to be categorized in the fair value hierarchy. The fair values presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Schedule of Investments. |